KEGG   DGROUP: Receptor tyrosine kinase inhibitorHelp
Entry
DG01917                     DGroup                                 

Name
Receptor tyrosine kinase inhibitor
Member
Erlotinib
 D07907  
Erlotinib (INN)
 D04023  
Erlotinib hydrochloride (JAN/USAN)  <JP/US>
Sunitinib
 D08552  
Sunitinib (INN)
 D06402  
Sunitinib malate (JAN/USAN)  <JP/US>
Sorafenib
 D08524  
Sorafenib (USAN/INN)
 D06272  
Sorafenib tosylate (USAN); Sorafenib tosilate (JAN)  <JP/US>
Lapatinib
 D08108  
Lapatinib (INN)
 D04024  
Lapatinib ditosylate (USAN); Lapatinib tosilate hydrate (JAN)  <JP/US>
Afatinib
 D09724  
Afatinib (USAN/INN)
 D09733  
Afatinib dimaleate (USAN); Afatinib maleate (JAN)  <JP/US>
Regorafenib
 D10138  
Regorafenib (USAN/INN)
 D10137  
Regorafenib hydrate (JAN)  <JP/US>
Cabozantinib
 D10062  
Cabozantinib (USAN)
 D10095  
Cabozantinib s-malate (USAN); Cabozantinib malate (JAN)  <US>
Lenvatinib
 D09919  
Lenvatinib (USAN/INN)
 D09920  
Lenvatinib mesylate (USAN); Lenvatinib mesilate (JAN)  <JP/US>
Quizartinib
 D09955  
Quizartinib (USAN/INN)
 D09956  
Quizartinib dihydrochloride (USAN); Quizartinib hydrochloride (JAN)  <JP>
Nintedanib
 D10481  
Nintedanib (USAN/INN)
 D10396  
Nintedanib esylate (USAN); Nintedanib ethanesulfonate (JAN)  <JP/US>
Cediranib
 D08881  
Cediranib (USAN/INN)
 D08883  
Cediranib maleate (JAN/USAN)
Tivozanib
 D09683  
Tivozanib (USAN/INN)
 D10190  
Tivozanib hydrochloride (USAN)
Motesanib
 D06678  
Motesanib
 D08947  
Motesanib diphosphate (USAN); Motesanib phosphate (JAN)
Varlitinib
 D09689  
Varlitinib (USAN/INN)
 D09690  
Varlitinib tosylate (USAN)
Crenolanib
 D10102  
Crenolanib (USAN)
 D10103  
Crenolanib besylate (USAN)
Toceranib
 D08503  
Toceranib (USAN)
 D08544  
Toceranib phosphate (USAN)
Golvatinib
 D10224  
Golvatinib (USAN)
 D10465  
Golvatinib tartrate (USAN)
Brivanib
 D09589  
Brivanib (USAN)
 D08878  
Brivanib alaninate (JAN/USAN/INN)
Dacomitinib
 D09883  
Dacomitinib (INN)
 D10514  
Dacomitinib (USAN); Dacomitinib hydrate (JAN)  <JP/US>
Amuvatinib
 D09864  
Amuvatinib (USAN/INN)
 D09865  
Amuvatinib hydrochloride (USAN)
D01977  
Gefitinib (JAN/USAN/INN)  <JP/US>
D05380  
Pazopanib hydrochloride (JAN/USAN)  <JP/US>
D06407  
Vandetanib (JAN/USAN/INN)  <JP/US>
D03218  
Axitinib (JAN/USAN)  <JP/US>
D10229  
Masitinib (INN)
D10766  
Osimertinib mesylate (USAN); Osimertinib mesilate (JAN)  <JP/US>
D03350  
Canertinib dihydrochloride (USAN)
D04025  
Mubritinib (USAN/INN)
D04696  
Lestaurtinib (USAN/INN)
D05029  
Midostaurin (JAN/USAN/INN)  <US>
D05819  
Semaxanib (USAN/INN)
D06005  
Tandutinib (USAN/INN)
D06285  
Vatalanib (USAN/INN)
D08907  
Dovitinib lactate (USAN); Dovitinib lactate hydrate (JAN)
D08950  
Neratinib (USAN/INN)
D09618  
Foretinib (USAN/INN)
D09635  
Linifanib (USAN/INN)
D09945  
Pegdinetanib (USAN/INN)
D10439  
Imgatuzumab (USAN/INN)
D10696  
Capmatinib (USAN/INN)
D10709  
Gilteritinib (USAN/INN)
 » expand
Class
Antineoplastic
 DG01918  Tyrosine kinase inhibitor

» Japanese version

DBGET integrated database retrieval system